First Patient Enrolled in ProstACT TARGET Study
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care in Australia,...
Source: prnewswire.com
Page 4 - Nat Lenzo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nat Lenzo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nat Lenzo Today - Breaking & Trending Today
First Patient Enrolled in ProstACT TARGET Study
MELBOURNE, Australia, Sept. 26, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest pro...
Source: businessinsider.com
First Patient Enrolled in ProstACT TARGET Study
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care in Australia,...
Source: prnewswire.com
First Patient Enrolled in ProstACT TARGET Study
MELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)and GenesisCare, the largest provider of integrated cancer care in Australia, today announce that a first patient has been enrolled in the Phase II ProstACT TARGET study of Telix's prostate cancer antibody therapy candidate TLX591 (177Lu-DOTA-rosopatamab), in patients experiencing a first recurrence of prostate-specific antigen (PSA) after initial therapy for prostate cancer. Telix's ProstACT therapeutic program is evaluating the efficacy of the Company's prostate-specif...
Source: philippinetimes.com
First Patient Enrolled in ProstACT TARGET Study
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care in Australia,...
Source: prnewswire.com